Sanofi (SNY) Other financing activities (2009 - 2025)

Sanofi has disclosed Other financing activities across 4 years of filings, most recently posting -$55.9 million for Q4 2025.

• In Q4 2025, Other financing activities fell 335.73% year-over-year to -$55.9 million; the TTM figure through Dec 2025 stood at -$165.7 million (down 666.88% YoY), while the FY2025 annual figure was -$55.9 million, down 330.2% from the prior year.
• Other financing activities came in at -$55.9 million for Q4 2025 at Sanofi, roughly flat from -$56.1 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of -$4.3 million in Q4 2023 to a low of -$56.1 million in Q3 2025.
• Average Other financing activities over 3 years is -$30.5 million, with a median of -$29.1 million recorded in 2024.
• Year-over-year, Other financing activities sank 197.95% in 2024 and slumped 335.73% in 2025.
• Over 3 years, Other financing activities stood at -$4.3 million in 2023, then slumped by 197.95% to -$12.8 million in 2024, then tumbled by 335.73% to -$55.9 million in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were -$55.9 million in Q4 2025, -$56.1 million in Q3 2025, and -$45.3 million in Q2 2025.